Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)

ClinicalTrials.gov ID: NCT00014989

Public ClinicalTrials.gov record NCT00014989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

As many more premature infants survive, the numbers of these infants with health problems increases. The rate of cerebral palsy (CP) in extremely premature infants is approximately 20%. Magnesium sulfate, the most commonly used drug in the US to stop premature labor, may prevent CP. This trial tests whether magnesium sulfate given to a woman in labor with a premature fetus (24 to 31 weeks out of 40) will reduce the rate of death or moderate to severe CP in the children at 2 years. The children receive ultrasounds of their brains as infants and attend three follow-up visits over two years to assess their health and development.

Study identification

NCT ID
NCT00014989
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
2,136 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 1997
Primary completion
Jan 31, 2007
Completion
May 31, 2007
Last update posted
Jul 11, 2019

1997 – 2007

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233
Dept of OB/GYN, University of Miami Miami Florida 33136
Northwestern University Chicago Illinois 60611
Dept of OB/GYN, Hutzel Hospital Detroit Michigan 48201
St. Luke's - Roosevelt Hospital New York New York 10019
University of North Carolina Chapel Hill North Carolina 27599
Forsyth Memorial Hospital, Wake Forest University School of Medicine Winston-Salem North Carolina 27103
The University Hospital, University of Cincinnati Cincinnati Ohio 45267-0794
Case Western University Cleveland Ohio 44109
Dept of OB/GYN, Ohio State University Columbus Ohio 43210
MCP Hahnemann University Philadelphia Pennsylvania 19102
Dept of OB/GYN Magee Womens Hospital Pittsburgh Pennsylvania 15213
Women and Infants Hospital Providence Rhode Island 02905-2499
Dept of OB/GYN, Southwestern Medical Center, University of Texas Dallas Texas 75235-9032
University of Texas Medical Branch - Galveston Galveston Texas 77555
University of Texas - Houston Houston Texas 77030
University of Utah Medical Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00014989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00014989 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →